🇺🇸 FDA
Patent

US 11466071

HLA class I-restricted t cell receptors against mutated RAS

granted A61KA61K38/00A61K40/11

Quick answer

US patent 11466071 (HLA class I-restricted t cell receptors against mutated RAS) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
44
CPC classes
A61K, A61K38/00, A61K40/11, A61K40/32, A61K40/4253